Midcap index scales all-time high despite flat close for benchmarks

Midcap index scales all-time high despite flat close for benchmarks



The Nifty Midcap 100 on Thursday rose 1.1 per cent to hit an all-time high of 62,003, even as the benchmark Sensex and Nifty ended the session flat. The Nifty Midcap 100 has been rising continuously for the last four sessions.

 


The benchmark Sensex and Nifty ended Thursday’s session flat. The Sensex ended at 77,845, down 114 points, or 0.2 per cent. The Nifty, meanwhile, ended the session at 24,327, down 4 points, or 0.02 per cent.

 


In this financial year, the Nifty Midcap 100 has gained 17.8 per cent after rising a mere 1.89 per cent in the previous financial year. Though the midcap index hit an all-time high, the Nifty Smallcap 100 remains 4.9 per cent away from its record high, while the Nifty is 7.6 per cent below its all-time high.

 
 


“Mid- and small-cap stocks have rallied because valuations had turned attractive after a prolonged correction since September 2024, with many counters falling 40-50 per cent from their September peaks. The ceasefire holding between the US and Iran has improved risk sentiment, while strong participation from retail investors and domestic institutions continues to provide liquidity support to the broader market,” said Chokkalingam G, founder of Equinomics.

 


Chokkalingam added that retail investors are increasingly gravitating towards midcaps because they offer unique thematic growth opportunities, unlike the moderate growth prospects in sectors such as IT and FMCG in the large-cap space.

 


“While benchmark indices and largecaps may remain subdued due to muted foreign investor inflows and concerns over rupee depreciation, mid- and small-caps could continue to outperform on strong domestic participation, though investors should remain cautious as signs of froth are beginning to emerge,” Chokkalingam said.

 


The overall market breadth remained strong, with 2,704 stocks advancing and 1,572 declining. The Nifty Smallcap 100 rose 0.87 per cent. INDIA VIX, a gauge of market volatility, declined 0.34 per cent to 16.62.

 


Foreign portfolio investors were net sellers worth Rs 341 crore, while domestic institutions were net buyers worth Rs 441 crore. Hindustan Unilever, which declined 1.95 per cent, was the biggest drag on the Sensex among its constituents.



Source link

Sun Pharmaceutical receives credit ratings from CRISIL and ICRA

Sun Pharmaceutical receives credit ratings from CRISIL and ICRA


Sun Pharmaceutical Industries (Sun Pharma) announced that CRISIL has reaffirmed the rating of the company’s long term bank facilities at CRISIL AAA and short term bank facilities and commercial paper at CRISIL A1+.

CRISIL has placed the ‘Crisil AAA’ rating on the long-term bank facilities on ‘Rating Watch with Developing Implications’. This rating action follows Sun Pharma’s announcement dated 27 April 2026, about signing a definitive agreement to acquire Organon & Co. (announcement).

CRISIL has further communicated that it will remove the rating from watch and announce its final rating action post a comprehensive assessment of this acquisition.

Further, ICRA has reaffirmed the rating on the long-term bank facilities for Sun Pharma, at ICRA AAA; Stable and short-term bank facilities and commercial paper at ICRA A1+ after taking note of the announcement.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: May 07 2026 | 7:50 PM IST



Source link

Sun Pharmaceutical receives credit ratings from CRISIL and ICRA

PNC Infratech secures road project of Rs 194 cr


From Lucknow Development Authority

PNC Infratech has emerged as L1 (First Lowest) bidder for a project of Lucknow Development Authority, Uttar Pradesh entailing construction of 4 Lane Flyover with 2 loops and 2 ramps at Shaheed Path Intersection, RHS bank of Gomti River, Lucknow (UP) on EPC Basis, on 7 May 2026 for a quoted price of Rs. 194.40 crore.  

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: May 07 2026 | 7:16 PM IST



Source link

Sun Pharmaceutical receives credit ratings from CRISIL and ICRA

Sonata Software Q4 PAT climbs 25% QoQ to Rs 130 cr


Sonata Software reported 25.05% jump in consolidated net profit to Rs 130.50 crore despite a 17.67% decline in revenue from operations to Rs 2536.19 crore in Q4 FY26 over Q3 FY26.

On a year on year (YoY) basis, the companys consolidated net profit jumped 21.36% while revenue from operations fell 3.1% in Q4 FY26.

Profit before tax (PBT) climbed stood at Rs 170.17 crore in Q4 FY26, up 20.87% QoQ and up 12.88% YoY. EBITDA stood at Rs 208.7 crore, registering the growth of 4.2% QoQ.

Revenue from domestic product & services stood at Rs 1,759.2 crore, down 25% QoQ.

In International IT Services segment, revenues for Q4 FY26 stood at Rs 779.2 crore, up 5.5% QoQ. In USD terms, revenue stood at $82.4 million and remained largely flat sequentially. However, in constant currency (CC), revenue witnessed a 0.6% QoQ growth.

 

On annual basis, the companys consolidated net profit rose 9.35% to Rs 464.39 crore on 5.36% increase in revenue from operations to Rs 10,701.24 crore in FY26 oer FY25.

Rajsekhar Datta Roy, CEO-designate of Sonata Software said: We won 2 large deals in Q426 and remain confident on Sonatas growth momentum, by becoming the strategic partners to our clients to enable the AI modernization journey. We will continue to invest in AI capabilities and partnerships, to further accelerate our pivot to AI.

Sujit Mohanty, MD & CEO of Sonata Information Technology, said: This quarter, we achieved strong performance in our core cloud platform offerings. We successfully acquired new clients for our cloud services and data protection solutions business areas. We realized YoY growth from key accounts.

Meanwhile, the companys board recommended final dividend of Rs 4.15 per equity share on a face value Re 1 for the financial year ended 31st March, 2026.

Sonata Software is primarily engaged in the business of providing Information Technology (IT) Services and Solutions to its various customers in the United States of America, Europe, Middle East, Australia and India.

The counter rose 0.52% to end at Rs 271.05 on the BSE.

Powered by Capital Market – Live News



Source link

Sebi discontinues investor risk reduction access platform for stock brokers

Sebi discontinues investor risk reduction access platform for stock brokers



Market regulator Sebi on Thursday discontinued the Investor Risk Reduction Access (IRRA) platform for stock brokers with immediate effect, citing its redundancy amid stronger business continuity and cyber resilience frameworks in the securities market.


The IRRA platform, operationalised on October 1, 2023, was designed to provide stock brokers with an alternative access point for trading during the disruption of trading services offered by them, the regulator said.


However, Sebi noted that several technology-driven measures introduced over the past few years have significantly strengthened stock brokers’ operational resilience.


These measures include operationalisation of Business Continuity Planning and Disaster Recovery (BCP-DR) requirements, enhanced cyber security and cyber resilience frameworks, implementation of Market Security Operations Centre (M-SoC), and strengthening of the technical glitch framework.

 


According to the regulator, stock brokers have also adopted significant technological advancements that enable seamless transition between primary and alternate sites during disruptions, along with the emergence of independent cold sites for business continuity.


Sebi further said stock exchanges already provide an alternative contingency trading framework, the Contingency Pool Trading facility, which allows brokers to square off outstanding open positions for clients during business disruptions through dedicated terminals connected to the exchange trading platform.


The regulator noted that stock exchanges informed Sebi that the IRRA platform had become “structurally redundant”, as it has not been accessed by stock brokers since its inception.


“Since its inception, the platform has not been accessed by the stock brokers, largely due to the implementation of robust regulatory measures, significant technological innovations within trading operations and the availability of the Contingency Pool Trading facility.


“Accordingly, based on stakeholder feedback and the aforementioned factors, it has been decided to discontinue the IRRA platform with immediate effect,” Sebi said in its circular.


The regulator also advised stock exchanges to review and further strengthen the framework for the Contingency Pool Trading facility.



Source link

Sun Pharmaceutical receives credit ratings from CRISIL and ICRA

BSE Q4 PAT surges 61% YoY to Rs 797 cr


Bombay Stock Exchange (BSE) reported 61.27% jump in consolidated net profit to Rs 797.33 crore on 84.67% surge in revenue from operations to Rs 1563.51 crore in Q4 FY26 comapred with Q4 FY25.

Profit before tax (PBT) increased 61.35% YoY to Rs 1,063.45 crore in Q4 FY26.

Operating EBITDA excluding core settlement gurantee fund (SGF) increased 36% YoY to Rs 1,061 crore in Q4 FY26. Margin increased 68% in Q4 FY26 as compared with 57% in Q4 FY25.

On full year basis, the companys consolidated net profit climbed 88.32% YoY to Rs 2,496.98 crore on 63.46% rise in revenue from operations to Rs 4,833.95 crore in FY26 over FY25.

 

Average daily turnover stood at Rs 7,950 crore in FY26, compared with Rs 7,766.6 crore in FY25.

During FY26, a total of 1,771 mainboard IPOs were listed on the exchange, raising Rs 10,900 crore. In the SME segment, 62 IPOs were listed, mobilising Rs 14,600 crore during the year.

Meanwhile, the companys board declared a final dividend of Rs 10 per share of face value of Rs 2 each for FY26. The record date has been fixed as Friday, 10 July 2026 and payment will be made on or before Thursday, 17 September 2026.

Bombay Stock Exchange (BSE) provides an efficient and transparent market for trading in multiple asset classes including, equity, equity derivatives, currency derivatives, commodity derivatives, interest rate derivatives, SME, startups and debt instruments.

The scrip rallied 3.35% to settle at Rs 3,981 on the NSE.

Powered by Capital Market – Live News



Source link

YouTube
Instagram
WhatsApp